http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1246206-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d202e9e866984fe229f6facc38f1d740
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-65505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C381-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C381-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-5352
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-655
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C381-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C381-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-535
filingDate 1969-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_52094bfe14ccbba1defe12d07e785377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c04a4d24113e8c7fc4407de16838deb
publicationDate 1971-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-1246206-A
titleOfInvention Preparation of (cis-1,2-epoxypropyl)phosphonic acid and its salts and esters
abstract 1,246,206. (Cis 1,2 - epoxypropyl) - phosphonic acid and intermediates therefor. MERCK & CO. Inc. 12 May, 1969 [15 May, 1968], No. 23985/69. Heading C2C. (Cis-1,2-epoxypropyl)-phosphonic acid and its salts and esters are obtained by treating a formyl phosphonate, e.g. a compound in which R is a C 1 -C 5 alkyl, C 2 -C 5 alkenyl, aryl, or aralkyl radical with an ethylide which is substituted at the methylene carbon by an appropriate leaving group, i.e. a compound M#-CH#-CH 3 wherein M<SP>+</SP> is the leaving group, e.g. a di-(C 1 -C 5 )- alkoxy phosphinyl, di-(C 1 -C 5 ) alkyl or diaryl sulphonium, tri-(C 1 -C 5 )-alkyl- (or triaryl) - ammonium, di-(C 1 -C 5 )-alkyl sulphoxonium, tri-(C 1 -C 5 )-alkyl phosphonium or triaryl phosphonium cation. The process is suitably conducted in a solvent, e.g. an ether or dimethylsulphoxide, and the ethylide reactant may be prepared in situ in the solvent and the formyl phosphonate then added to the solution. When the products are esters they may be converted to the free (cis-1,2-epoxypropyl)-phosphonic acid, e.g. by hydrolysis with a mineral acid, hydrogenolysis, or treatment with trimethylchlorosilane followed by -aqueous hydrolysis. The phosphonic acid may then be converted to a salt, e.g. an alkali metal or alkaline earth metal salt, especially the calcium or disodium salt, by treatment with an aqueous solution of an appropriate base. Diethyl sulphoxonium ethylide is obtained by reacting diethyl sulphoxide with ethyl iodide in solution at 100-110‹ C. to form triethylsulphoxonium iodide and then treating the latter with sodium methylsulphonyl methylide in dimethyl sulphoxide. Triethylammonium ethylide is obtained by adding tetraethylammonium bromide in ether to an ethereal solution of phenyl lithium at 25‹ C. and decanting the supernatant liquid. Diethylsulphonium ethylide is obtained by reacting diethyl sulphide with ethyl bromide to form triethylsulphonium bromide and then treating the latter with an equivalent of sodium methyl sulphonyl methylide in dimethylsulphoxide.
priorityDate 1968-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523446
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449519999
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID637932
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID141233
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3283
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6332
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538066
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6397
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419522016
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414021918
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID148246880
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6263
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448082472
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419578737
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419522017
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419530576
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419530548
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559485
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3015009
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6285
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1385867
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419572063
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID679
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6340
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10154022
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21319574
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546014
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410552407
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9609
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6325
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559505
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410552406
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460341
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407330845
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3084169
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559542
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22290424
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447622745
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID102402

Total number of triples: 58.